Authors of a review found giving hepatitis C patients prophylactic antidepressants did not increase compliance with interferon-based treatment regimens. University of Texas researchers said depression may affect as many as 30% of HCV patients, but while antidepressants were associated with reduced symptoms, they did not lead to better treatment completion rates.

Related Summaries